What happens to an astronaut’s brain during a mission to Mars? Nothing good. It’s besieged by destructive particles that can forever impair cognition, according to a UC Irvine radiation oncology study appearing in the May 1 edition of Science Advances.
A class of drugs developed to treat immune-related conditions and cancer – including one currently in clinical trials for glioblastoma and other tumors – eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to UC Irvine researchers.
UC Irvine pediatric neurologist Dr. Ira Lott has received a five-year, $2.4 million National Institutes of Health grant to seek ways of preventing or delaying the onset of dementia in people with Down syndrome, who have an elevated risk of developing it by age 40.
Neurobiologist Frank LaFerla is taking the reins of the UC Irvine Institute for Brain Aging & Dementia, hoping to boost clinical offerings and move forward with a new building dedicated to Alzheimer’s disease research.
UCI collaborates with London orchestra on stroke rehabilitation program
Harvard researcher to build world-class, transdisciplinary program
UC Irvine research into aromas while sleeping sparks 226% cognitive increase
Two-year Alzheimer’s Association grant to support the novel research
UCI researchers dive deep in search of health-sleep links
Campus awarded $10 million NIH grant to analyze early-stage impact of tau protein deposits